REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Danpac Pharma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Surgical and Medical Instrument Manufacturing
Full name: Pt Danpac Pharma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pt Danpac Pharma is a company in Indonesia, with a head office in West Jakarta. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Pt Danpac Pharma was incorporated on December 11, 2003. The company’s latest financial report indicates a net sales revenue increase of 13.49% in 2024. Its total assets grew by 13.39% over the same period.

Headquarters
Green Sedayu Bizpark Blok DM 5 No. 31 E, Jl. Daan Mogot Km. 18, RT. 011 RW. 006
West Jakarta; Jakarta; Postal Code: 11840

Contact Details: Purchase the Pt Danpac Pharma report to view the information.

Website: http://www.danpacpharma.com

Basic Information
Registered Capital:
Purchase the Pt Danpac Pharma report to view the information.
Financial Auditors:
Purchase the Pt Danpac Pharma report to view the information.
Incorporation Date:
December 11, 2003
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Member
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Danpac Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
13.49%
Total Operating Revenue
13.49%
Total Assets
13.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?